子宮頸がんの化学放射線療法中の嘔吐に対する利尿薬投与:多施設共同後ろ向き研究
Naoya Tonomura1, Kensuke Yoshida2, Hajime Morita3
1Division of Hospital Pharmacy, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
Anticancer research
|February 27, 2026
まとめ
フロセミドは、子宮頸がん治療中の化学療法誘発性悪心・嘔吐(CINV)の予防において、マンニトールよりも良い選択肢となる可能性があります。化学放射線療法を受けている患者において、フロセミドはマンニトールと比較して嘔吐の頻度が低く、発現が遅いことと関連していました。
科学分野:
- 腫瘍学; 薬理学; 消化器病学
背景:
- 化学療法誘発性悪心・嘔吐(CINV)は、子宮頸がんの同時化学放射線療法(CCRT)における重大な課題です。
研究 の 目的:
- CCRTを受けている子宮頸がん患者における嘔吐の発生率とタイミングに対するマンニトールとフロセミドの影響を評価すること。
主な方法:
- 週1回のシスプラチンベースのCCRTを受けた485人の患者を対象とした多施設共同後ろ向き研究。
主要な成果:
- マンニトール群(18.4%)の方がフロセミド群(10.4%)よりも嘔吐の頻度が高かった。
- イベント発生までの時間解析では、CCRT中のマンニトールによる嘔吐発現がより早期であることが示された。
結論:
- CCRTを受けている子宮頸がん患者におけるCINVリスク管理において、フロセミドはマンニトールよりも適した選択肢となる可能性があります。
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
744
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
744
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
691
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
691
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
983
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
983
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
864
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
864
Imaging Studies for Cardiovascular System V: CT
448
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
448
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
315
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
315


